Pfizer's $10B Innovent Deal Boosts Cancer Drugs | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we'll explore a landscape teeming with strategic partnerships, groundbreaking clinical trial results, regulatory shifts, and innovative therapeutic approaches that are redefining patient care and drug development. Pfizer's monumental $10 billion collaboration with Innovent Biologics stands out as a testament to the shifting dynamics of the oncology secto...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Pharma and BioTech Daily
Eli Lilly & Boehringer Cut $1B+ Investments in Germany | Pharma and Biotech Daily
Legend Biotech's CAR T-Cell Breakthrough: 100% Response Rate | Pharma and Biotech Daily
Moderna-Merck Combo Cuts Melanoma Risk by 49% | Pharma and Biotech Daily
Akeso's Ivonescimab Shows 34% Death Risk Cut at ASCO | Pharma and Biotech Daily
Get summaries like this every morning.
Free AI-powered recaps of Pharma and BioTech Daily and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.